300142.SZ
沃森生物
SZSE · Healthcare · C 制造业 · CN
CNY 14.90
−7.45%Margins
Gross margin
74.0%
EBITDA margin
24.5%
EBIT margin
13.9%
Net margin
11.9%
FCF margin
4.1%
3.9%
Return on equity
2.6%
Return on assets
3.8%
Return on invested capital
0.21x
Asset turnover
CNY 632.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026